Comparison between Sonalis Consumer Products IPO and Vilin Bio Med IPO.
Sonalis Consumer Products IPO is a SME Fixed Price IPO proposed to list at BSE SME while Vilin Bio Med IPO is a SME Fixed Price proposed to list at NSE SME.
| Sonalis Consumer Products IPO | Vilin Bio Med IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Expert Global Consultants Pvt.Ltd. | Inventure Merchant Banker Services Pvt.Ltd. |
| Registrar | Purva Sharegistry (India) Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Beeline Broking Ltd. | Rikhav Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Sonalis Consumer Products IPO is up to ₹2.68 Cr whereas the issue size of the Vilin Bio Med IPO is up to ₹11.38 Cr. The final issue price of Sonalis Consumer Products IPO is ₹30.00 per share and of Vilin Bio Med IPO is ₹30.00 per share.
| Sonalis Consumer Products IPO | Vilin Bio Med IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹30.00 per share | ₹30.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 4000 shares | 4000 shares |
| Fresh Issue Size | 8,92,000 shares | 37,92,000 shares |
| Fresh Issue Size (Amount) | up to ₹2.68 Cr | up to ₹11.38 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 8,92,000 shares | 37,92,000 shares |
| Issue Size Total (Amount) | up to ₹2.68 Cr | up to ₹11.38 Cr |
Sonalis Consumer Products IPO opens on Jun 07, 2023, while Vilin Bio Med IPO opens on Jun 16, 2023. The closing date of Sonalis Consumer Products IPO and Vilin Bio Med IPO is Jun 09, 2023, and Jun 21, 2023, respectively.
| Sonalis Consumer Products IPO | Vilin Bio Med IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jun 07, 2023 | Jun 16, 2023 |
| Issue Close | Jun 09, 2023 | Jun 21, 2023 |
| Basis Of Allotment (Tentative) | Jun 14, 2023 | Jun 26, 2023 |
| Initiation of Refunds (Tentative) | Jun 15, 2023 | Jun 27, 2023 |
| Credit of Share (Tentative) | Jun 16, 2023 | Jun 29, 2023 |
| Listing date (Tentative) | Jun 19, 2023 | Jun 30, 2023 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Sonalis Consumer Products IPO P/E ratio is 6.56, as compared to Vilin Bio Med IPO P/E ratio of 24.59.
| Sonalis Consumer Products IPO | Vilin Bio Med IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials |
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 73.12 | 91.45 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 38.59 | 64.52 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 6.56 | 24.59 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹41.85 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 14.76% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 8.58% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.71 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹10.08 | ₹0.10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 19.60% | 1.15% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Sonalis Consumer Products IPO Retail Individual Investors (RII) are offered 4,48,000 shares while in Vilin Bio Med IPO retail investors are offered 4,48,000 shares. Qualified Institutional Buyers (QIB) are offered in Sonalis Consumer Products IPO and in Vilin Bio Med IPO.
| Sonalis Consumer Products IPO | Vilin Bio Med IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 52,000 shares | 2,08,000 shares |
| QIB | ||
| NII | 4,44,000 shares | 18,96,000 shares |
| RII | 4,48,000 shares | 18,96,000 shares |
| Employee | ||
| Others | ||
| Total | 8,92,000 shares | 37,92,000 shares |
Sonalis Consumer Products IPO subscribed 43.48x in total, whereas Vilin Bio Med IPO subscribed 2.80x.
| Sonalis Consumer Products IPO | Vilin Bio Med IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 38.41x | 1.28x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 48.31x | 4.31x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 43.48x | 2.80x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
